OREANDA-NEWS. DuPont (NYSE: DD), a science company that brings world-class, innovative products, materials, and services to the global marketplace, today announced fourth-quarter 2015 operating earnings of $0.27 per share compared with $0.57 per share in the prior year.  GAAP1 (losses) earnings were ($0.26) per share, compared with $0.63 per share in the prior year.  Refer to Schedule B for details of significant items.

For the full-year 2015, DuPont delivered operating earnings of $2.77 per share, compared with $3.36 per share in the prior year.  GAAP1 earnings were $2.09 per share, compared with $3.39 per share in the prior year.

Fourth-quarter sales were $5.3 billion, down 9 percent versus prior year due to negative impacts from currency (8 percent) and volume (1 percent).  Full-year sales were $25.1 billion, down 12 percent versus prior year due to negative impacts from currency (7 percent), portfolio (2 percent) and volume (3 percent).

DuPont's board of directors approved a first-quarter dividend of 38 cents per share, the 446th consecutive quarterly dividend since the company's first dividend in the fourth quarter of 1904. The first-quarter dividend of 38 cents per share of common stock is payable on March 14, 2016, to stockholders of record at the close of business on Feb. 12, 2016. Regular quarterly dividends of $1.125 per share on the $4.50 series preferred stock and $0.875 cents per share on the $3.50 series preferred stock also were declared, both payable on April 25, 2016, to stockholders of record as of April 8, 2016.

On Dec. 11, 2015, DuPont and The Dow Chemical Company announced that their boards of directors unanimously approved a definitive agreement under which the companies will combine in an all-stock merger of equals.  The combined company will be named DowDuPont.  The merger is expected to close in the second half of 2016, subject to customary closing conditions, including regulatory approvals, and approval by both Dow and DuPont shareholders. The parties intend to subsequently pursue a separation of DowDuPont into three independent, publicly traded companies through tax-free spin-offs. These separations would occur as soon as feasible, subject to regulatory and board approval.  

"We are making progress on key initiatives, including further improving our cost structure and restructuring our organization to enhance our competitiveness," said Ed Breen, Chair and CEO of DuPont. "In this pivotal year for DuPont we have three priorities: deliver operating earnings growth while positioning our businesses to compete successfully over the long term; continue to improve our capital allocation and working capital performance; and complete the proposed merger of equals with Dow.  Our merger process is on track. We are meeting key milestones and have begun our planning to create three strong, highly focused, independent businesses in agriculture, material science and specialty products."

Global Consolidated Net Sales – 4th Quarter and Full Year

 
   

December 31, 2015

 

Percent Change Due to:

   

$

 

%

Change

 

Local Price and

       

Portfolio /

       

Product Mix

Currency

 

Volume

 

Other

                       

(Dollars in millions)

                     

     U.S. & Canada

 

$ 1,884

 

(4)

 

(2)

-

 

(1)

 

(1)

     EMEA *

 

1,193

 

(16)

 

(1)

(12)

 

(2)

 

(1)

     Asia Pacific

 

1,417

 

(5)

 

(3)

(4)

 

-

 

2

     Latin America

 

805

 

(18)

 

5

(23)

 

-

 

-

                       

Total Consolidated Net Sales

$ 5,299

 

(9)

 

-

(8)

 

(1)

 

-

                       

* Europe, Middle East & Africa

   

Twelve Months Ended

               
   

December 31, 2015

 

Percent Change Due to:

   

 

$

 

%

Change

 

Local Price and

         

Portfolio /

       

Product Mix

 

Currency

 

Volume

 

Other

                         

(Dollars in millions)

                       

     U.S. & Canada

 

$  10,755

 

(6)

 

(2)

 

(1)

 

(2)

 

(1)

     EMEA *

 

6,043

 

(17)

 

2

 

(15)

 

(2)

 

(2)

     Asia Pacific 

 

5,617

 

(9)

 

(2)

 

(3)

 

(2)

 

(2)

     Latin America

 

2,715

 

(23)

 

2

 

(15)

 

(9)

 

(1)

                         

Total Consolidated Net Sales

$  25,130

 

(12)

 

-

 

(7)

 

(3)

 

(2)

                         

*  Europe, Middle East & Africa

Segment Net Sales – 4th Quarter and Full Year

 
   

Three Months Ended

               
   

December 31, 2015

 

Percent Change Due to:

   

 

$

 

 

% Change

 

Local Price and

         

Portfolio /

       

Product Mix

 

Currency

 

Volume

 

Other

(Dollars in millions)

                       

Agriculture

 

$    1,550

 

(11)

 

6

 

(16)

 

-

 

(1)

Electronics & Communications

493

 

(14)

 

(4)

 

(2)

 

(8)

 

-

Industrial Biosciences

 

301

 

(6)

 

(1)

 

(5)

 

-

 

-

Nutrition & Health

 

807

 

(4)

 

-

 

(8)

 

4

 

-

Performance Materials

 

1,284

 

(11)

 

(6)

 

(5)

 

(1)

 

1

Safety & Protection

 

864

 

(8)

 

(1)

 

(3)

 

(4)

 

-

Other

 

-

                   

Consolidated Net Sales

 

5,299

 

(9)

 

-

 

(8)

 

(1)

 

-

   

Twelve Months Ended

               
   

December 31, 2015

 

Percent Change Due to:

           

Local Price and

         

Portfolio /

   

$

 

% Change

 

Product Mix

 

Currency

 

Volume

 

Other

(Dollars in millions)

                       

Agriculture

 

$ 9,798

 

(13)

 

3

 

(9)

 

(6)

 

(1)

Electronics & Communications

2,070

 

(13)

 

(4)

 

(2)

 

(7)

 

-

Industrial Biosciences

1,171

 

(6)

 

(3)

 

(6)

 

3

 

-

Nutrition & Health

 

3,256

 

(8)

 

-

 

(9)

 

2

 

(1)

Performance Materials

5,305

 

(12)

 

(4)

 

(6)

 

1

 

(3)

Safety & Protection

 

3,527

 

(9)

 

-

 

(4)

 

(1)

 

(4)

Other

 

3

                   

Consolidated Net Sales

25,130

 

(12)

 

-

 

(7)

 

(3)

 

(2)

Operating Earnings – 4th Quarter and Full Year

           
         

Change vs. 2014

(Dollars in millions)

4Q15

 

4Q14

 

$

 

%

Agriculture

$        (54)

 

$        134

 

$        (188)

 

-140%

Electronics & Communications

87

 

92

 

(5)

 

-5%

Industrial Biosciences

55

 

44

 

11

 

25%

Nutrition & Health

85

 

79

 

6

 

8%

Performance Materials

281

 

326

 

(45)

 

-14%

Safety & Protection

182

 

205

 

(23)

 

-11%

Other

(83)

 

(92)

 

9

 

10%

Total segment operating earnings 

553

 

788

 

(235)

 

-30%

               

Exchange gains (losses) 

(24)

 

152

 

(176)

 

nm

Corporate expenses 

(160)

 

(134)

 

(26)

 

19%

Interest expense

(82)

 

(87)

 

5

 

-6%

Operating earnings before income taxes 

287

 

719

 

(432)

 

-60%

Provision for income taxes on operating earnings 

(51)

 

(200)

 

149

   

Less: Net (loss) attributable to noncontrolling interests 

(3)

 

-

 

(3)

   

Operating earnings

$        239

 

$        519

 

$        (280)

 

-54%

               

Operating earnings per share 

$       0.27

 

$       0.57

 

$       (0.30)

 

-53%

         

Change vs. 2014

(Dollars in millions)

YTD 2015

 

YTD 2014

 

$

 

%

Agriculture

$      1,646

 

$      2,352

 

$        (706)

 

-30%

Electronics & Communications

359

 

336

 

23

 

7%

Industrial Biosciences

203

 

192

 

11

 

6%

Nutrition & Health

373

 

369

 

4

 

1%

Performance Materials

1,216

 

1,267

 

(51)

 

-4%

Safety & Protection

704

 

772

 

(68)

 

-9%

Other

(258)

 

(256)

 

(2)

 

-1%

Total segment operating earnings 

4,243

 

5,032

 

(789)

 

-16%

               

Exchange gains (losses)

93

 

254

 

(161)

 

nm

Corporate expenses 

(573)

 

(677)

 

104

 

-15%

Interest expense

(322)

 

(377)

 

55

 

-15%

Operating earnings before income taxes 

3,441

 

4,232

 

(791)

 

-19%

Provision for income taxes on operating earnings 

(932)

 

(1,112)

 

180

   

Less: Net income attributable to noncontrolling interests 

6

 

10

 

(4)

   

Operating earnings

$      2,503

 

$      3,110

 

$        (607)

 

-20%

               

Operating earnings per share 

$       2.77

 

$       3.36

 

$       (0.59)

 

-18%

               
               

The following is a summary of business results for each of the company's reportable segments comparing fourth quarter with the prior year, unless otherwise noted.

Agriculture – An operating loss of $54 million resulted in $188 million lower operating earnings as increases in local price and cost reductions and continued productivity improvements were more than offset by a $139 million negative currency impact and about a $30 million negative impact from the continued shutdown of the LaPorte manufacturing facility.  Prior year results benefitted from a timing impact from performance-based compensation adjustments and $36 million in gains from portfolio actions. Excluding the impact of currency, the segment would have reported operating earnings of $85 million.

Electronics & Communications – Operating earnings of $87 million decreased $5 million, or 5 percent, as cost reductions and continued productivity improvements were more than offset by competitive pressures impacting Solamet® paste. Excluding the impact of currency, operating earnings would have decreased by about 10 percent.

Industrial Biosciences – Operating earnings of $55 million increased $11 million, or 25 percent, as benefits from cost reductions and continued productivity improvements were partially offset by a $2 million negative impact from currency and slightly lower pricing. Operating margins improved 450 basis points. Excluding the impact of currency, operating earnings would have increased 30 percent.

Nutrition & Health – Operating earnings of $85 million increased $6 million, or 8 percent, as cost reductions, continued productivity improvements and broad-based volume growth led by probiotics, cultures, and ingredient systems, more than offset the absence of an $18 million gain on termination of a distribution agreement in the prior year and a $12 million negative currency impact.  Excluding the impact of currency, operating earnings would have increased by about 23 percent.

Performance Materials – Operating earnings of $281 million decreased $45 million, or 14 percent. Cost reductions, continued productivity improvements and increased demand for Performance Polymers in global automotive markets, were more than offset by lower ethylene price and volume and $19 million of negative currency impact. Operating earnings included a $33 million benefit from the sale of a business and tax benefits associated with a manufacturing site.  Excluding the impact of currency, operating earnings would have decreased by about 8 percent.

Safety & Protection – Operating earnings of $182 million decreased $23 million, or 11 percent. Cost reductions and productivity improvements were more than offset by lower demand and a $2 million negative currency impact. Volume declines in Nomex® thermal-resistant fiber, Kevlar® high-strength material and Sustainable Solutions offerings were driven by weakness in the oil and gas industry and in military spending.  Excluding the impact of currency, operating earnings would have decreased by about 10 percent.

2016 Outlook
Current difficult global economic conditions in agriculture and slower growth in emerging markets are expected to continue, challenging the company's sales growth in 2016. The company expects 2016 operating earnings of $2.95 to $3.10 per share, including an expected benefit of $0.64 per share from the 2016 global cost savings and restructuring plan.  The increase in the expected benefit results from identification of additional savings that will be delivered from the existing plans, including previously announced employee reduction estimates. The benefit from the 2016 global cost savings and restructuring plan will be weighted toward the second half of 2016 as specific actions continue to be implemented in the first and second quarters.  2016 operating earnings also includes approximately $0.30 per share of estimated negative currency impact due to the continued strengthening of the U.S. dollar, pressuring both the top and bottom line.   A higher base tax rate, reflecting the expected geographic mix of earnings, is expected to negatively impact operating earnings by $0.05 - $0.10 per share.  The currency impact is expected to be most significant in the first half of the year due to a further weakening of the U.S dollar.  Given the seasonality of the company's operating earnings from Agriculture in the northern hemisphere, the company anticipates approximately two-thirds of the expected currency impact to occur in the first half of 2016. Excluding the impact of currency, the guidance for full-year operating earnings per share, including expected benefits from cost savings and share repurchases, represents a 17-23 percent increase year over year.
Use of Non-GAAP Measures
Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP are provided in schedules A, C and D.

About DuPont
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.